Core Laboratories (CLB) Reports In-Line Q3 EPS, Q4 Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $9.65 -1.23%
Financial Fact:
Income Tax Expense (Benefit): 2.08M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Income Tax Expense (Benefit): 2.08M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.83, in-line with the analyst estimate of $0.83. Revenue for the quarter came in at $197.3 million versus the consensus estimate of $201.06 million.
Core Laboratories sees Q4 2015 EPS of $0.63-$0.67, versus the consensus of $0.75. Core Laboratories sees Q4 2015 revenue of $180 million, versus the consensus of $191.94 million.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CoreCivic (CXW) Misses Q3 EPS by 1530c; raises guidance
- Liberty Latin America (LILA) Reports Q3 results
- Primerica (PRI) Tops Q3 EPS by 37c, Beats on Revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
